175278-54-3 Usage
Uses
Used in Organic Synthesis:
5-NITRO-2-(2-PYRIDYLTHIO)BENZALDEHYDE is utilized as a reagent in various organic synthesis processes. Its unique structure and reactivity contribute to the formation of a wide range of complex organic molecules, making it an indispensable component in the synthesis of new compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 5-NITRO-2-(2-PYRIDYLTHIO)BENZALDEHYDE serves as an intermediate in the synthesis of diverse pharmaceutical compounds. Its role in the development of new drugs is significant, as it can be incorporated into the molecular structures of potential therapeutic agents.
Used in Chemical Reactions:
5-NITRO-2-(2-PYRIDYLTHIO)BENZALDEHYDE is also employed in a variety of chemical reactions, where its nitro and pyridylthio groups participate in different types of chemical transformations. This versatility allows it to be a key player in the synthesis of a broad spectrum of chemical products.
Used in Research and Development:
Due to its unique chemical properties, 5-NITRO-2-(2-PYRIDYLTHIO)BENZALDEHYDE is often used in research and development settings to explore new chemical reactions, investigate its reactivity, and understand its potential applications in various fields, including material science and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 175278-54-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,7 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 175278-54:
(8*1)+(7*7)+(6*5)+(5*2)+(4*7)+(3*8)+(2*5)+(1*4)=163
163 % 10 = 3
So 175278-54-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H8N2O3S/c15-8-9-7-10(14(16)17)4-5-11(9)18-12-3-1-2-6-13-12/h1-8H
175278-54-3Relevant academic research and scientific papers
Nitroarylhydroxymethylphosphonic acids as inhibitors of CD45
Beers, Scott A.,Malloy, Elizabeth A.,Wu, Wei,Wachter, Michael P.,Gunnia, Uma,Cavender, Druie,Harris, Crafford,Davis, Janet,Brosius, Ruth,Pellegrino-Gensey, J. Lee,Siekierka, John
, p. 2203 - 2211 (2007/10/03)
A series of nitroarylhydroxymethylphosphonic acids was synthesized and evaluated as inhibitors of CD45. It was discovered that both the alpha hydroxy and nitro groups are essential for activity. Potency is enhanced by the addition of a large lipophilic group on the aryl ring adjacent to the phosphonic acid moiety. Kinetics studies have shown that these compounds are competitive inhibitors and thus bind at the active site of this enzyme.
